NCT05360680 2026-01-22A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic CancersCue BiopharmaPhase 1 Completed42 enrolled
NCT02085148 2024-04-22A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard TherapyBayerPhase 1 Completed62 enrolled
NCT02498665 2023-11-14A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesSumitomo Pharma America, Inc.Phase 1 Completed24 enrolled